Search Within

Adam B Olshen

Formats
  1. Journal Article (53)
  2. Meeting Abstract (50)
  3. Book Section (3)
  4. Conference Paper (1)
Groups
  1. Department of Pathology and Laboratory Medicine (46)
  2. GSK Faculty (46)
  3. Department of Medicine (38)
  4. Surgery (33)
  5. Human Oncology and Pathogenesis Program (31)
  6. Tow Center for Developmental Oncology (TCDO) (30)

More Groups

People
  1. Marc Ladanyi (27)
  2. Raju Chaganti (20)
  3. Jane Houldsworth El Naggar (18)
  4. Agnes Viale (14)
  5. Julie Feldstein (13)
  6. Raymond Comenzo (13)

More People

Years
  1. 2015 (1)
  2. 2013 (1)
  3. 2011 (8)
  4. 2010 (5)
  5. 2009 (5)
  6. 2008 (17)

More Years

Publications
  1. Blood (15)
  2. Cancer Research (11)
  3. Journal of Clinical Oncology (9)
  4. Modern Pathology (7)
  5. Laboratory Investigation (6)
  6. Gynecologic Oncology (4)

More Publications

Publishers
  1. American Association for Cancer Research (15)
  2. American Society of Hematology (15)
  3. Nature Publishing Group (11)
  4. American Society of Clinical Oncology (9)
  5. Nature Research (7)
  6. Elsevier Inc. (6)

More Publishers

Results (107)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Development and validation of a gene-based model for outcome prediction in germ cell tumors using a combined genomic and expression profiling approach
    Journal Article

    Korkola, J. E.; Heck, S.; Olshen, A. B.; Feldman, D. R.; Reuter, V. E.; Houldsworth, J.; Bosl, G. J.; Chaganti, R. S. K.
    PLoS ONE (2015)

    Fulltext@MSK | Save
  • Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein
    Journal Article

    Kobos, R.; Nagai, M.; Tsuda, M.; Merl, M. Y.; Saito, T.; Lae, M.; Mo, Q.; Olshen, A.; Lianoglou, S.; Leslie, C.; more...
    Journal of Pathology (2013)

    Fulltext@MSK | Save
  • The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma
    Journal Article

    Oricchio, E.; Nanjangud, G.; Wolfe, A. L.; Schatz, J. H.; Mavrakis, K. J.; Jiang, M.; Liu, X.; Bruno, J.; Heguy, A.; Olshen, A. B.; more...
    Cell (2011)

    Fulltext@MSK | Save
  • Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data
    Meeting Abstract

    Wang, L.; Motoi, T.; Khanin, R.; Socci, N.; Olshen, A.; Mertens, F.; Bridge, J.; Dal Cin, P.; Rushing, E. J.; Fanburg-Smith, J.; more...
    Modern Pathology (2011)

    Fulltext@MSK | Save
  • Testing and validating high throughput genomic analysis of FFPE samples: Systematic gene expression differences between matched frozen and FFPE samples due to rapid mRNA degradation signals
    Meeting Abstract

    Cabal, R.; Khanin, R.; Viale, A.; Socci, N.; Lucito, R.; Olshen, A.; Zhang, J.; Gerald, W.; Powers, S.; Ladanyi, M.
    Laboratory Investigation (2011)

    Fulltext@MSK | Save
  • Testing and validating high throughput genomic analysis of FFPE samples: Systematic gene expression differences between matched frozen and FFPE samples due to rapid mRNA degradation signals
    Meeting Abstract

    Cabal, R.; Khanin, R.; Viali, A.; Socci, N.; Lucito, R.; Olshen, A.; Zhang, J.; Gerald, W.; Powers, S.; Ladanyi, M.
    Modern Pathology (2011)

    Fulltext@MSK | Save
  • The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
    Journal Article

    Bott, M.; Brevet, M.; Taylor, B. S.; Shimizu, S.; Ito, T.; Wang, L.; Creaney, J.; Lake, R. A.; Zakowski, M. F.; Reva, B.; more...
    Nature Genetics (2011)

    Fulltext@MSK | Save
  • Integrated genomic analyses of ovarian carcinoma
    Journal Article

    The Cancer Genome Atlas Research Network
    Nature (2011)

    Fulltext@MSK | Save
  • Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy
    Journal Article

    Brevet, M.; Shimizu, S.; Bott, M. J.; Shukla, N.; Zhou, Q.; Olshen, A. B.; Rusch, V.; Ladanyi, M.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Antitumor activity of SNX-2112, a synthetic heat shock protein-90 inhibitor, in Met-amplified tumor cells with or without resistance to selective MET inhibition
    Journal Article

    Bachleitner-Hofmann, T.; Sun, M. Y.; Chen, C. T.; Liska, D.; Zeng, Z.; Viale, A.; Olshen, A. B.; Mittlboeck, M.; Christensen, J. G.; Rosen, N.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save